Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Dapagliflozin Compared With Glimepiride on Body Composition in Patients With Type 2 Diabetes Inadequately Controlled With Metformin

NCT02564926 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT02564926
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02564926 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Dapagliflozin Compared With Glimepiride on Body Composition in Patients With Type 2 Diabetes Inadequately Controlled With Metformin
Lead sponsor
AstraZeneca
Phase
Phase 4
Overall status
Completed
Start date
January 5, 2016
Completion date
January 15, 2018
Enrollment
125 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2